Columbia Weill Cornell PsychiatryPardes, Herbert
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers. Dec 5, 2024 0 7 Psychology & Psychiatry ...